H1 FY25 Update - Record Sales

• The record order intake reflects strengthening demand and improved conversion across Compumedics’ core sleep and neuro platforms, following a targeted USA commercial refocus • MEG: the Company secured one MEG order in H1 FY26, with further MEG opportunities expected to progress in H2 FY26 2. Revenue Reported (unaudited) • The result reflects improved execution and delivery cadence, converting or